Molecular analysis of Mycobacterium isolates from patients with BCG-induced lymphadenitis
The Bacillus Calmette-Guérin (BCG) vaccine is administered to all newborns within the first days of life for the prevention of tuberculosis (TB) in many of the developing countries, including Iran. BCG vaccine is prepared from a special strain of Mycobacterium bovis. This vaccine is safe, but local...
Main Authors: | Farahnoosh Doustdar, Fatemeh Shahi, Fatemeh Fallah, Hossein Goudarzi, Maryam Baniasad, Bahman Pourabbas |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | International Journal of Mycobacteriology |
Subjects: | |
Online Access: | http://www.ijmyco.org/article.asp?issn=2212-5531;year=2015;volume=4;issue=5;spage=135;epage=135;aulast=Doustdar;type=0 |
Similar Items
-
Bacille Calmette–Guérin (BCG) Vaccine Induced Tuberculous Lymphadenitis: A Case Report
by: Kalyan Sapkota
Published: (2020-12-01) -
Advances in the characterization of a proteol iposome derived from Mycobacterium bovis BCG as vaccine candidate against tuberculosis
by: Nadine Alvarez-Cabrera, et al.
Published: (2014-12-01) -
Histopathologic differences in granulomas of Mycobacterium bovis bacille Calmette Guérin (BCG) vaccinated and non-vaccinated cattle with bovine tuberculosis
by: C. Kanipe, et al.
Published: (2022-11-01) -
BCG-SSI® vaccine-associated lymphadenitis: Incidence and management
by: Arnis Engelis, et al.
Published: (2016-01-01) -
Clinical Course of Bacillus Calmette-Guerin Lymphadenitis
by: Dayoung Ko, et al.
Published: (2022-04-01)